Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.5B | 9.6B | 10.0B | 10.0B |
Cost of revenue | 3.2B | 3.2B | 3.4B | 3.4B |
Gross profit | 6.3B | 6.5B | 6.6B | 6.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.2B | 2.2B | 2.2B | 2.2B |
Operating income | 1.8B | 2.1B | 2.3B | 2.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 14.5M | 25.8M | 20.6M | 56.4M |
Other income expense | — | — | — | — |
Pretax income | 1.9B | 2.2B | 2.4B | 2.4B |
Tax provision | 473.4M | 555M | 619.6M | 630.1M |
Net income | 1.5B | 1.6B | 1.7B | 1.8B |
Basic EPS | — | 10.5 | 11.2 | 11.4 |
Diluted EPS | — | 10.2 | 11 | 11.2 |
Basic average shares | — | 155.3M | 155.3M | 155.3M |
Diluted average shares | — | 158.7M | 158.7M | 158.4M |
EBITDA | 2.4B | 2.6B | 2.8B | 2.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |